A comparative study of butaperazine, chlorpromazine and placebo in chronic schizophrenics
- 30 April 1970
- journal article
- clinical trial
- Published by Elsevier in Psychosomatics
- Vol. 11 (2) , 120-126
- https://doi.org/10.1016/s0033-3182(70)71674-5
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Evaluation of a new antipsychotic agent. Butaperazine maleate (repoise maleate)Published by American Medical Association (AMA) ,1968
- Sensitivity to a Phenothiazine (Butaperazine)Canadian Psychiatric Association Journal, 1968
- Evaluation of butaperazine in chronic schizophreniaClinical Pharmacology & Therapeutics, 1968
- Clinical Evaluation of ButaperazinePsychosomatics, 1967
- Therapeutic studies in “therapy resistant” schizophrenic patientsComprehensive Psychiatry, 1966
- Étude Comparative de la Butapérazine et de la Prochlorpérazine Chez le Schizophrène ChroniqueCanadian Psychiatric Association Journal, 1965
- EVALUATION OF A NEW PHENOTHIAZINE DERIVATIVE IN THE TREATMENT OF SCHIZOPHRENIAAmerican Journal of Psychiatry, 1964
- Comparison of butaperazine and perphenazine: A double-blind controlled studyPsychopharmacology, 1964
- COMPARISON OF BUTYRYLPERAZINE AND TRLFLUOPERAZINE IN CHRONIC SCHIZOPHRENIC SUBJECTSAmerican Journal of Psychiatry, 1962
- STUDY OF BUTYRYLPERAZINE (BAYER 1362)American Journal of Psychiatry, 1961